Voy

Private

LondonHealthcare & Life Scienceshttps://www.joinvoy.com/

Last Round

Debt

Nov 1, 2025

Total Funding Raised

$352.5M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Voy is a digital health company that provides science-led treatments for weight loss, menopause, hair loss, and testosterone.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, D2C Brands, Subscription Commerce, Patient Engagement

Business Model

B2C

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

telemedicinedigital healthweight loss medicationGLP-1hormone replacement therapyHRTtestosterone replacement therapyTRTdirect-to-consumerD2Csubscription healthcareat-home diagnosticspatient engagementonline pharmacyhealth techAI health assistant

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Voy Comps

Public and private peers based on sector, stage, and business model.

Voy comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Voy Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Debt	Nov 1, 2025
Debt	Nov 1, 2024
Series B	Sep 15, 2024
Series B	May 21, 2024
Series A	Mar 30, 2021
Seed	Jan 15, 2019

View all Funding Rounds

Key People

Founding team and executive leadership

Vladimir Minakov

CTO At FORMEL Skin, CTO - Germany

Executive Team

Voy Investors

Notable investors and investment history

Voy investors
Investor	Rounds
GISEV	Series A
CASSIUS	Seed
Waldencast	Series A
Felix Capital	Seed, Series B, Series A
Venture Highway	Debt
FJ Labs	Series A
Sonoma Brands Capital	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jul 6, 2026
Open roles increased from 0 to 33, representing 31% of headcount.
Jun 30, 2026
Grew 32% QoQ, from 289 to 382 employees.

View all signals

Voy Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Voy Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Voy's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon

Employee Range382

Year Founded2022

Last FundingNov 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.